ArticleMicrobial biotechnology2022

Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species.

Lin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.